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Abstract
Background: NK cells have been long time considered as cytotoxic lymphocytes competent in killing virus-infected cells
and tumors. However, NK cells may also play essential immuno-regulatory functions. In this context, the real existence of a
defined NK subset with negative regulatory properties has been hypothesized but never clearly demonstrated.
Methodology/Principal Findings: Herein, we show the in vitro generation from human peripheral blood haematopoietic
progenitors (PB-HP), of a novel subset of non-cytolytic NK cells displaying a mature phenotype and remarkable immuno-
regulatory functions (NK-ireg). The main functional hallmark of these NK-ireg cells is represented by the surface expression/
release of HLA-G, a major immunosuppressive molecule. In addition, NK-ireg cells secrete two powerful immuno-regulatory
factors: IL-10 and IL-21. Through these factors, NK-ireg cells act as effectors of the down-regulation of the immune response:
reconverting mature myeloid DC (mDC) into immature/tolerogenic DC, blocking cytolytic functions on conventional NK
cells and inducing HLA-G membrane expression on PB-derived monocytes. The generation of ‘‘NK-ireg’’ cells is obtained, by
default, in culture conditions favouring cell-to-cell contacts, and it is strictly dependent on reciprocal trans-presentation of
membrane-bound IL-15 forms constitutively and selectively expressed by human CD34
+ PB-HP. Finally, a small subset of
NKp46
+ HLA-G
+ IL-10
+ is detected within freshly isolated decidual NK cells, suggesting that these cells could represent an in
vivo counterpart of the NK-ireg cells.
Conclusions/Significance: In conclusion, NK-ireg cells represent a novel truly differentiated non-cytolytic NK subset with a
self-sustainable phenotype (CD56
+ CD16
+ NKp30
+ NKp44
+ NKp46
+ CD94
+ CD69
+ CCR7
+) generated from specific pSTAT6
+
GATA3
+ precursors. NK-ireg cells could be employed to develop new immuno-suppressive strategies in autoimmune
diseases, transplant rejection or graft versus host diseases. In addition, NK-ireg cells can be easily derived from peripheral
blood of the patients and could constitute an autologous biotherapic tool to be used combined or in alternative to other
immuno-regulatory cells.
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Introduction
Natural Killer (NK) cells, traditionally considered to be major
innate effector cells, have been long time relegated to the job of
killing virus-infected cells and tumors. However, more and more
evidence has been obtained that NK cells play positive or negative
regulatory effect by secreting variouscytokines or cell-to-cell contact
andmaintainimmunehomeostasis[1–5].Asa consequence,subsets
of NK cells in mouse and human have been defined based on their
cell-surface phenotype and functional properties that are shaped by
environmental factors among which cytokines play a major role [1–
5]. In this context, the differentiation of CD34
+ HP into NK cells is
strictly dependent on Interleukin 15 (IL-15) [6,7]. However, the
mechanism by which IL-15 mediates NK cell differentiation is not
fully understood and it seems to be only partially dependent on the
soluble form of this cytokine.
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2241Although soluble IL-15 can bind to the IL-15R complex and
induce signals in a manner similar to other cytokines upon
interaction with their receptors [8,9], there is increasing evidence
that IL-15 mediates many specific biological responses in cell
membrane-associated forms [10–12]. In this context, membrane-
bound IL-15 (mb-IL-15) anchored through the IL-15Ra chain on
the surface of Bone Marrow (BM) myeloid accessory cells, in the
mouse model, is essential for normal development of NK cells
[13,14], whereas IL-15 trans-presentation seems to be more
complex in human as suggested by the detection of additional
forms of mb-IL-15 independent on the IL-15Ra [10,12].
Indeed, human spleen myofibroblasts display a mb-IL-15
associated with IL-15Rbcc chains [12], which is necessary and
sufficient to trigger in vitro the differentiation of circulating
progenitors into cytolytic NK cell [15]. Finally, prostate cancer
cells express a trans- membrane IL-15, anchored in a IL-15R-
independent fashion, which can participate in reverse signaling
and/or act in a juxtacrine fashion promoting the development of
bystander cells [10]. These data indicate that IL-15 trans-
presentation by accessory cells seems to be an important
requirement for NK cell homeostasis [13-15], while it is still
poorly defined whether IL-15 trans-presented by CD34
+ HP may
play a role in this process.
In this respect, we have recently observed that human
uncommitted CD34
+ PB-HP constitutively express mb-IL-15
[16], the involvement of which in the commitment towards the
NK differentiation pathway has not been explored. In order to
clarify this point, we expanded human CD34
+ PB-HP adapting
previously described protocols, based on the use of media
supplemented with stem cell factor (SCF) and flt3 ligand (FL),
that induce an enrichment in CD34
+ CD56
2 NK progenitors
(NKP) [17,18]. Surprisingly, the results revealed that membrane-
bound IL-15 forms present on human PB-HP [10,12], in
conditions favouring cell-to-cell contact, promote, through recip-
rocal trans-presentation, the generation of a novel subset of mature
non-cytolytic NK cells. These NK cells secrete major regulatory
factors (IL-10, IL-21 and HLA-G) that likely mediate tolerogenic/
immunosuppressive activities on myeloid DC maturation, on NK
associated cytolytic functions and on PB monocytes phenotype and
function.
The real existence of a NK subset with negative regulatory
functions has been hypothesized but never clearly demonstrated
[2,5]. Herein, we show the mb-IL-15 dependent generation from
human PB-HP, of a novel subset of mature non–cytolytic NK cells
(NK-ireg), whose main functional hallmark is the surface
expression/release of a major immunosuppressive molecule
HLA-G [19], and that display remarkable regulatory functions.
Materials and Methods
Cytokines and reagents
Human recombinant IL-4, soluble IL-15Ra/Fc Chimera (s-IL-
15Ra), soluble IL-21R/Fc Chimera (s-IL-21R), the Cytofix/
Cytoperm reagent are from R&D Systems (Lille, France).
Recombinant Stem Cell Factor (SCF), IL-12, IL-21, GM-CSF
and FMS-like tyrosine kinase 3 ligand (Flt3-L) were purchased
from Immunotools (Friesoythe, Germany). LPS (E. Coli, 055:B5),
Brefaldin A, PHA, and PMA were from Sigma-Aldrich (S. Q.
Fallavier France). Antibodies used in this study are listed in table 1.
Cell Lines
The acute T cell lymphoblastic leukaemia Jurkat, the erythro-
leukemic cell line K562, the melanoma cell line FON, the
promyelocytic leukemia cell line HL-60 and the neuroblastoma
Neuro2a were cultured in RPM1 1640 medium (GIBCO, Eragny,
France) supplemented with 2 mM L-glutamine, HEPES, 1% of
penicillin streptomycin solution (GIBCO), 10% heat-inactivated
fetal calf serum (PAA Laboratories Les Mureaux, France).
Table 1. Antibodies, origin and use
Abs anti- origin use
IL-15Ra (AF 247) R&D Systems (Lille, France). FLC+Neu
IL-10-PE, IL-15-PE, IFNc-FITC FLC
IL-12 FLC
IL-21 eBioscience (San Diego USA) W.B.
IL-15Rb (6E8) Y. Jacques (U463 INSERM, Nantes, France) Neu
IL-2/IL-15-cc (TUGh4), BD PharMingen (Le Pont de Claix, France). Neu
CD107a, CD85j FLC
CD11c-PE, CD16-PE, CD34-PE, CD38-PE, CD56-PE, CD69-PE,
HLA-DR-FITC
Immunotools (Friesoythe, Germany) FLC
Perforin-FITC, Granzyme B-FITC FLC CF
CD80-PE, CD83-PE, CD86-PE, NKp30-PE, NKp44-PE, NKp46-PE,
NKG2D-PE, CD94-PE ,CD161-PE
Beckman Coulter (Villepinte, France) FLC
isotype matched Ig controls FLC
CCR7 BD Biosciences (San Diego, United States) FLC
HLA-G (4H84), TGF-b1 pSTAT3, pSTAT6, GATA3 Santa-Cruz Biotechnologies (Tebu, Le Parray en Yvelines, France) FLC+WB W.B
PE-or FITC-labeled goat anti-mouse and goat anti-rabbit Jackson ImmunoResearch Laboratories, France) FLC secondary Abs.
Alexa Fluor488-labelled goat anti-rabbit and goat anti-mouse Molecular Probes, Interchim, France FLC CF secondary Abs.
horseradish peroxidase (HRP) labelled goat anti mouse Amersham Biosciences, Orsay, France W.B. secondary Abs.
HLA-G (MEMG/9-PE, 87G azide free, 0IG-FITC) ExBio , Prague, FLC,Neu, CM
FLC=flow cytometry, W.B.=Western Blot, CF=Confocal Microscopy, Neu.=neutralization
doi:10.1371/journal.pone.0002241.t001
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+ PB-HP and commitment to the NK
pathway
CD34
+ PB-HP were purified (.90%) from fresh PBMC of
healthy donors as previously described [20] according to standard
procedures by a direct immunomagnetic method (Milteneyi
Biotech, Paris, France). Then, PB-HP were committed to NK
pathway expanding the cells in STEMa2A medium (Stem Alpha,
Saint Clement les places, France) supplemented with SCF and FL
(both at 100 ng/ml), a condition that favours and enriches the
frequency of NK progenitors [18]. PB-HP were seeded at
5610
5cells/ml, in order to magnify cell-cell interactions.
Isolation of d-NK and PB-derived NK cells
Samples were obtained at 9 to 12 weeks of gestation from
singleton pregnancies of mothers requesting termination of the
pregnancy for social reasons or who were undergoing evacuation
of retained products of conception following spontaneous
pregnancy failure. The study was approved by the relevant
institutional review boards and all patients gave their written
informed consent according to the Declaration of Helsinki.
Decidual tissue was separated from specimens obtained by suction
evacuation of the uterus. The total decidual tissue was then
minced into fragments of 1 mm
3 and digested for 1 hour at room
temperature under agitation in PBS with 200 U/mL hyaluron-
idase (Sigma) and 1 mg/mL collagenase type IV (Seromed, Berlin,
Germany). The cell suspension was filtered through sterile
stainless-steel 100-mm wire mesh and washed once in PBS. The
mononuclear cell population was isolated using Ficoll-Hypaque
density gradient (Sigma), washed twice in PBS, and used for cell
isolation or fluorescence analysis. To obtain enriched NK cells,
both decidual mononuclear cells and PBMC were depleted of
CD4
+, CD14
+, CD19
+, CD3
+,Vd1
+, and Vd2
+ cells by negative
selection using appropriate mAbs followed by goat antimouse-
coated Dynabeads (Dynal, Oslo, Norway) and immunomagnetic
depletion. Peripheral-blood lymphocytes were isolated from
peripheral blood from healthy donors and pregnant woman using
Ficoll-Hypaque density gradient either directly or after enrichment
(.95%) for NK cells using Rosettesep (StemCell Technologies,
Meylan, France). PB-derived NK cells were used as freshly isolated
resting cells or activated with 100 U/ml of IL-2 for 4 days.
Generation of PB-derived human allogeneic myeloid DC
and PB-NKP/DC co-culture
Monocytes were purified from PBMC (.95%) by using the
CD14-Adembeads (Ademtech, Pessac, France) and DC were
generated by culturing monocytes in RPMI 1640 complete medium
supplemented with GM-CSF and IL-4 (both at 50 ng/ml). On day
6, immature DC were incubated with LPS (1 mg/ml) for 48 h to
generate myeloid mature DC (mDC). NK/DC cross-talk was
studied co-culturing for 24–48 h mDC with allogenic 3 weeks-old
PB-NKP, or using PB-NKP cell supernatants. DC morphology was
assessed on cytospin preparations after RAL 555 staining Kit
(Abcells, Tampere France). Pictures were obtained with an Olympus
microscope (Arcueil, France) equipped with a 40x objective lens
using a CoolPix 995 numeric camera (Nikon Paris, France).
Cytotoxicity assay
IL-2 activated NK cells and 3 weeks-old PB-NKP were tested
for cytolytic activity in a standard 4-h
51Cr release assay as
previously described [21] in the presence or absence of 5 ng/ml of
IL-12. K562 human leukemic cells were used as target in
experiments of natural cytotoxicity. The effector-to-target (E/T)
ratios were 10:1.
Mixed lymphocyte reaction (MLR)
Allogeneic PBMC were labelled with 1 mM of 5,6-carboxy-
fluorescein diacetate-succinimyl ester (CFSE) in PBS/0.1% BSA
for 10 min at 37uC and washed with complete medium. Cells were
then seeded in 96-well flat bottom microtiter plates (Costar) at
1610
6/ml in complete culture medium with mitomycin treated
mDC (DC/PBMC ratio 1/10) pre-incubated or not for 24 h with
PB-NKP (mDC/PB-NKP ratio 1/1). Proliferation was analyzed
by flow cytometry after 5 days.
Cell Phenotype and cytokines detection by flow
cytometry
Cell surface antigen expression was evaluated on suspensions of
living cells by cytofluorimetry analysis as previously described [20].
Since IL-10, TGFb and IFNc may be detected as surface-bound
cytokines [21–23], we exploited this property investigating the
production of these cytokines by flow cytometry after rapid direct
staining (30 min at 4uC) of a suspension of living cells. Cell surface
cytokine expression was validated by further intracellular detection
using the Cytofix/Cytoperm reagent according to the manufac-
turer’s instructions. Flow cytometric analysis was performed using
FACScalibur (Becton Dickinson, Saint Quentin Yvelines, France),
using CellQuest (BD Biosciences) and WinMDI (Scripps Research
Institute, La Jolla, CA) software programs. At least 5000 events
were analyzed in each test.
Confocal laser-scanning microscopy
Expression of granzyme B or perforin and nuclear localization
of phospho-STAT6 and GATA3 were analyzed by confocal
microscopy on PB-NKP pre-treated or not with s-IL-15Ra for 1h.
Nuclear localization of phospho-STAT3 was analyzed in LPS-
activated mDC co-cultured overnight or not with PB-NKP. Cell
permeabilization, intracellular staining and processing for confocal
microscopy were performed as previously described [20]. The
slides were examined by confocal laser microscopy (Leica TCS
Confocal System, Wetzler, Germany).
Western Blotting
PB-NKP and control cell lines were used: Jurkat cells stimulated
for 30 min with IL-4 at 10 ng/ml for pSTAT-6 and GATA3, HL-
60 cell line for IL-21 and FON melanoma cell line for HLA-G
detection. PBL and IL-2-stimulated NK cells were used as negative
controls. Total cell lysates and pre-filtered, 10-fold concentrated
cell supernanants were subsequently processed for Western Blot
analysis as previously described [20]. Immunodetection of the
protein blotted was determined using a Fujifilm Intelligent Dark
Box II. b-actin was used as internal control.
RT-PCR analysis for human IL-10, IL-21
Total RNA was isolated using the NucleoSpin RNA II kit
(Macherey-Nagel, Duren, Germany) according to the manufac-
turer’s instructions. One mg of total RNA was then reverse-
transcribed using the SuperScript II Reverse transcriptase
(Invitrogen, Milano, Italy) in a final volume of 20 ml. Two mlo f
the cDNA were separately amplified, in a final volume of 25 ml,
with 2.5 IU Taq polymerase (Genecraft, Germany), in the
presence of 1 mM of the primers specific for IL-10, IL-21, and
for the housekeeping gene b-actin. The following human primers
were used: IL-10, forward: 59-GCTCTGTTGCCTGGTCC-
TCC, reverse : 59-CTCCACGGCCTTGCTCTTGT (58uC); IL-
21, forward : 59-GAAGTGAAAACGAGACCAAGGT, reverse:
59-CTGCAAGTTAGATCCTCAGG (52uC); b-actin, forward:
59-GGCATCGTGATGGACTCCG reverse: 59-GCTGGAAGG-
IL-15 and Generation of NKreg
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PCR Sprint thermal cycler (Hybaid, Ashford, UK). Ten ml of PCR
products were then analysed on 1–2% agarose gel stained with
ethidium bromide.
IL-10 and IL-15 enzyme-linked immunosorbent assay
(ELISA)
Culture cell supernatants were harvested at different times of
culture and tested in triplicate for IL-10 and IL-15 production by
ELISA (Immunotools, Friesoythe, Germany and R&D systems:
Lille, France) according to the manufacturer’s instructions. The
ELISA plate was read at OD 405 nm on a Microplate ELISA
reader (Titertek multiskan plus, Puteaux, France).
Data Analysis
All experiments were performed in at least three independent
assays, which yielded highly comparable results. Data are
summarized as means+/2S.D. Approval was obtained from the
INSERM institutional review board for these studies. Informed
consent was provided according to the Declaration of Helsinki.
Results
Detection of membrane-bound IL-15 on proliferating
human Peripheral Blood CD34
+ progenitors
Quiescent human haematopoietic progenitors constitutively
secrete IL-15 that plays a role in their homeostasis but is not
competent for sustaining their autonomous commitment to the
NK cell pathway [20,24]. We investigated the form and function
of IL-15 expressed by CD34
+ HP cultured under conditions
(STEMaAmedium supplemented with 100 ng/ml of SCF and
FL) that were shown to induce an enrichment in CD34
+ CD56
2
NK cell progenitors (NKP) [17,18]. In figure 1, flow cytometric
analysis shows that PB-HP (Fig. 1A), but not BM- derived ones
(Fig. 1B) express a mb-IL-15. This form is detected on freshly
isolated PB-HP (Fig. 1A, D0) and it is maintained during the
following days in culture (Fig. 1A, D12). The treatment of these
cells with neutralizing mAbs directed against the IL-15Ra subunit
(10 mg/ml) only partially inhibited (20%) the detection of mb-IL-
15 (Fig. 1A). The consistent finding of residual expression of mb-
IL-15, not inhibited by anti-IL-15Ra mAbs suggested the presence
of an IL-15 form anchored in an IL-15R-independent fashion.
Figure 1. Membrane-bound IL-15 detection on proliferating human circulating CD34
+ HP. CD34
+ PB- and BM-HP were committed to the
NK cell lineage, culturing in STEMaAmedium supplemented with 100 ng/ml of FL and KL. The presence of membrane-bound IL-15 was evaluated
staining the cells with anti-IL-15 mAb 247-PE (continuous line) or isotype-matched control Abs (shadowed peaks), followed by FACS analysis. (A)
Constitutive expression and effect of the treatment at 37uc with 10 mg/ml of neutralizing mAbs directed against the IL-15Ra subunits (dotted lines).
(B) No mb-IL-15 expression on BM-NKP. (C) PB-NKP cells were also treated with acidic buffer (pH 3.5; dotted lines) which does not modify their mb-IL-
15 expression. (D, E) In contrast, acidic shock and treatment with neutralizing anti-IL-15Ra mAbs cause the suppression of mb-IL-15 form expressed
by the erythroleukemic cell line TF1. (F) Induction of mb-IL-15-dependent reverse signal. Western Blot analysis of MAPKinase ERK1/2 activation after
15 minutes treatment of PB-NKP with the soluble recombinant IL-15Ra.( G) ELISA assay shows that PB-NKP do not secrete IL-15. RCC and mDC
supernatants were used as negative and positive controls of secretion respectively.
doi:10.1371/journal.pone.0002241.g001
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interaction with IL-15Ra is released by acidic treatment [11],
IL-15 anchored to the cell membrane is not [10]. We observed
that acidic treatment does not reduce mb-IL-15 on PB-HP
(Fig. 1C, D12), while in the erythroleukemic cell line TF1, the
treatment with neutralizing mAbs against IL-15Ra subunit or the
acidic shock causes the disappearance of the mb-IL-15 anchored
through the IL-15Ra (Fig. 1D and 1E). In addition, treatment of
PB-HP with the soluble IL-15Ra induces the phosphorylation of
the MAPkinase ERK 1/2 (Fig. 1F), indicating that this treatment
activates, as recently reported in cells expressing a trans-
membrane IL-15 form, a reverse signal.
Altogether the residual expression of mb-IL-15 following
treatment with anti-IL-15R mAbs, its resistance to acidic
treatment and the activation of a reverse signal in response to
the soluble receptor suggest the existence of an IL-15 form
anchored in an IL-15R independent fashion that could correspond
to the trans-membrane IL-15 form recently described on human
prostate cancer cells [10]. Finally, IL-15 ELISA assay on the
supernatants from cultured PB-HP, show that there no detectable
IL-15 secretion. Mature myeloid dendritic cells [25] and renal
cancer cells [26] were employed as positive and negative controls
of IL-15 secretion (Fig. 1G). These results suggest that, soon after
immunopurification, two parameters could differentiate PB-HP
from BM-HP: the expression of mb-IL-15 and absence of IL-15
secretion.
NK commitment of PB-HP in the absence of exogenous
lymphokines
We next investigated whether the human CD34
+ PB-HP
expressing mb-IL-15 could trans-present IL-15 each other
mimicking the in vivo effect of BM myeloid accessory cells on
bystander BM-HP and trigger their commitment towards the NK
cell lineage in the absence of exogenous lymphokines. Freshly
isolated PB-HP expresses the CD34
+ CD38
+ CD56
dull CD16
2
CD161
2 CD14
2 surface phenotype (Fig. 2, D0). When these cells
are maintained at high cell density that favors cell to cell contact
(5610
5 cells/ml), there was a progressive expansion of uni-lineage
homogeneous committed progenitors that, growing in suspension,
progressively acquired the phenotype of mature NK cells. On day
7, these progenitors acquired markers typical of immature NK
cells. However, they still maintained low expression of CD34
(CD34
low CD56
+ CD16
low CD161
+ CD94
2/+) (Fig. 2, D7). At this
stage, we frequently observed that a small subset of CD1a
adherent cells stems from the cells growing in suspension. This
small subset represents less then 3% of the total cell population,
but could somehow influence the maturation process of these PB-
NKP [16].
After 2 weeks in culture, cells lost CD34 expression and
acquired additional NK cell markers (CD69
+ CD94
+ NKG2D
+
NKp30
+NKp44
+ NKp46
+) (Fig. 2, D14). After three weeks, the
totality of cultured cells displayed the phenotype of mature NK
Figure 2. Autonomous NK commitment of PB-HP. Commitment into the NK pathway of PB-HP was evaluated by flow cytometry at different
times in culture, analyzing CD34, CD38 and the NK markers CD56, CD16, CD161, CD94, NKp30, NKp44, NKp46, NKG2D, CD69 and CCR7. Shadowed
peaks represent staining with isotype control Abs. Continuous lines represent staining with the indicated Abs. The frequency of PB-HP represents
about 0.1% of mononuclear cells of the peripheral blood. The data are representative of more than 30 separate experiments.
doi:10.1371/journal.pone.0002241.g002
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+ CD16
+ CD161
+ CD69
+ CD94
+ NKG2D
+ NKp30
+
NKp44
+ NKp46
+ CCR7
+) (Fig. 2, D21).
Morphology and cytolytic potential of NK cells generated
by PB-NKP
Phenotypical characterization was strengthened by morphological
analysis showing that after three weeks in culture PB-HP autono-
mously committed into the NK pathway display a typical lymphoid
morphology (Fig. 3A). In addition, confocal microcopy demonstrated
a spotted intracytoplasmic expression of perforin and granzyme B,
suggesting their localization within granule-like structures as observed
in conventional activated NK cells (Fig. 3B and 3C).
We next compared PB-NKP with IL-2 activated conventional
NK cells for their cytolytic potential. Both types of NK cells,
Figure 3. Autonomous NK commitment of PB-HP: morphology and expression of cytolytic granules. (A) Ral 555 staining on 3-weeks-old
PB-HP cultured in in STEMaAmedium supplemented with 100 ng/ml of FL and SCF. PB-NKP exhibit a lymphoid morphology. (B) Intracytoplasmic
expression of perforin and granzyme B in PB-NKP and in PB activated conventional NK cells was analyzed by confocal microscopy. Both cell types
were fixed, permeabilized, and stained for perforin and granzyme B. As negative controls, cells were incubated with mouse IgG, and the second
reagent. (C) Analysis of the cytolytic activity of freshly purified NK cells from healthy donors (open boxes) and from PB-NKP (grey boxes) against
51Cr-
labelled K562 cells. NK cell effectors, treated or not for 18 hours with IL-12 (5 ng/ml), were assayed in a 4-h
51Cr-release assay against K562 cells in a
dilution of E/T cell ratios (10:1) in duplicate wells. Data are representative of three experiments performed.
doi:10.1371/journal.pone.0002241.g003
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cells cytolytic activity and functional maturation, were challenged
in a 4 hours
51Cr-release assay against K562 cells (Fig. 3D). In
these experiments, conventional IL-2 stimulated NK cells, display
cytolytic activity (50%) which is significantly increased by IL-12
treatment (70%). In contrast, PB-NKP cells do not exhibit any
cytolytic potential even at the 10:1 ratio and in the presence of IL-
12. Similar results were obtained using IL-15 or IL-18 alone or
associated to IL-12 (data not shown).
Pattern of activation of transcription factors during NK
cell commitment of PB-derived HP
Subsequently, we analyzed the transcription factor profile
expressed by PB-NKP at different culture intervals. We found
that, differently from what previously described in Cord Blood
NKP (CB-NKP) [12], PB-NKP were characterized by an early
and stable activation of STAT6 and the expression of GATA3,
two transcription factors that play a key role in the induction of
Th2 responses [27,28]. Indeed, Western Blot analysis revealed that
the specific bands of phospho-STAT6 (pSTAT6, 110 kDa) and of
GATA3 (48 kDa) were detected in the total lysates of these
progenitors, but not of freshly isolated NK cells. GATA3
+ Jurkat
cells stimulated with IL-4 were used as positive controls for
pSTAT6 detection [29] (Fig. 4A).
Moreover, the constitutive expression of activated STAT6 and
GATA3 in PB-NKP was further confirmed by confocal microscopy
showing, that a large majority of the cells displayed nuclear
localization of pSTAT6 and GATA3 (Fig. 4B left panels, nuclear
yellow staining). Analysis performed on different donors showed
that the constitutive activation of STAT6 and GATA3 is a constant
and specific feature of these PB-NKPpSTAT6+GATA3+ (NKPSG).
Since exposure of the mb-IL-15 present on PB-HP to the soluble
IL-15Ra/FcChimera(s-IL-15Ra)inducesareversesignalactivating
the MAPkinase ERK (Fig. 1F), we investigated if other signaling
pathways were modified after incubation of PB-NKP with the
soluble receptor. Confocal microscopy shows that treatment with the
s-IL-15Ra inhibits within one hour the nuclear translocation of the
two Th2 transcription factors pSTAT6 and GATA 3 (Fig. 4B right
panels). In addition, flow cytometry demonstrates that PB-NKP
produce Th2 cytokines as shown by the important intracellular
storage of IL-5 and IL-4. Intracellular detection of both Th2
cytokinesisinhibitedafter 24 hoursexposure tothe s-IL-15Ra chain
(Fig. 4C). These data show that, in PB-NKP, the constitutive
activation of Th2 transcription factors and production of Th2
cytokines is controlled by the endogenous mb-IL-15.
NK cell commitment of PB-HP is controlled by
endogenous mb-IL-15
The constitutive expression of mb-IL-15 and the finding that
PB-HP could evolve rapidly towards the NK cell pathway
suggested that the differentiation of PB-HP into NKPSG may be
under the control of endogenous mb-IL-15. In order to test this
hypothesis, we attempted to interfere with the mb-IL-15 functions
by the use of neutralizing mAbs recognizing the different IL-15R
subunits in order to interfere with the juxtacrine loop activated
through IL-15 trans-presentation. Early addition of IL-15Ra
neutralizing mAbs to PB-HP resulted, within four days, in
inhibition of CD56 while CD34 surface expression was preserved
(Fig. 5, D4). The same treatment was repeated after four days in
culture and PB-HP were analyzed 48 hours later. Addition of
neutralizing IL-15Ra mAbs (AF247) resulted in down-regulation
of the expression of CD56, CD16 and CD161, while the initial
expression of the CD34 molecule was maintained (Fig. 5, D6). In
contrast, the use of anti-IL-15Rbcc neutralizing mAbs did not
modify the surface expression of NK markers (data not shown)
suggesting a direct role for the IL-15Ra chain in receiving the
signal of trans-presented IL-15 for NK commitment.
NKPSG cells display regulatory functions on the
maturation of myeloid dendritic cells
Although NKPSG cells expressed activating NK receptors and
cytolytic granules they did not mediate natural cytotoxicity (lysis of
K562 cells, Fig. 3D), failed to express the degranulation-marker
CD107a and to produce IFN-c upon cross-linking of CD16 or
Natural Cytotoxicity Receptor (NCR) molecules (data not shown).
The absence of the above mentioned NK cell functions led us to
investigate whether NKPSG could exert some unusual functions.
Recent interest has focused on the interaction between NK cells
and dendritic cells (DC). In vitro and in vivo studies have
demonstrated various effects resulting from NK-DC interactions,
including cytokine production, DC maturation and NK cell
activation and proliferation [30]. Thus, we analyzed the effect of
the interaction between NKPSG cells and myeloid DC. CD14
+
monocytes were cultured for 6 days in the presence of GM-CSF
and IL-4 achieving their differentiation into immature dendritic
cells (iDC) (CD1a
+ CD14
2 CD80
+ CD83
2 CD86
+ HLA-DR
2,
data not shown). Their stimulation with LPS (1 mg/ml) induces
within 48 hours the phenotype (CD80
++ CD83
+ CD86
++ HLA-
DR
high CD25
+) (Fig. 6A), the morphology (development of several
fillopodial extensions) (Fig. 6B) and function (IL-12 p70 produc-
tion) of mature dendritic cells (mDC). Mature DC, co-cultured
with NKPSG cells, displayed after 48 hours a strong down-
regulation of the co-stimulatory molecules (CD80 and CD86) and
other maturation markers (CD83, HLA-DR and CD25). More-
over, they stopped producing IL-12p70, thus re-establishing the
phenotype (Fig. 6A) and morphology of iDC (Fig. 6B). In addition,
DC acquired a tolerogenic-like phenotype characterized by the
induction of a membrane-bound form of TGFb (Fig. 6A), by the
nuclear translocation of pSTAT3 (Fig. 6C). Similar results were
obtained in independent experiments using cell supernatants of
NKPSG cells. Indeed, figure 5A shows that the mDC treatment
with the cell supernatants from NKPSG cultures resulted in a
significant decrease of the expression of CD80, CD83, CD86,
HLA-DR and IL-12p70. Use of cell supernatant from conven-
tional PB-derived NK cells had no effect (data not shown). While
mDC were capable of triggering proliferation of allogeneic naı ¨ve
PBMC, mDC exposed to NKPSG cells appeared to be very poor
inducers (Fig. 6D). After five days in culture, naı ¨ve allogeneic
PBMC showed less than 10% of proliferating cells, while in sister
cultures co-cultured with mitomycin-treated mDC the percentage
of proliferating cells raised up to 60%. In contrast, in PBMC co-
cultured with mitomycin-treated mDC previously exposed to
NKPSG cells only 20% underwent proliferation.
NKPSG cells induce HLA-G expression on PB monocytes
and inhibit the CD107a and IFNc surface expression on
NK cells activated by NCR cross-linking
PB-derived monocytes are important effector cells of the
immune response causing its activation or its down-regulation
depending on the panel of the immuno-regulatory factors that they
produce [31]. Thus we tested if NKPSG cells could influence the
behavior of PB monocytes. In figure 6E flow cytometry shows that
control PB monocytes do not express on their membrane
detectable amounts of HLA-G molecule, whereas 48 hours
treatment with the supernatant of NKPSG cells induces HLA-G
molecule expression on PB monocytes.
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human NK cells stimulated by the cross-linking of NCR expressed
on their surface CD107a within 3 hours, and IFN-c within
24 hours. When conventional PB-derived NK cells were incubated
overnight with NKPSG cells, a complete inhibition of CD107a
expression and IFN-c production could be detected. Remarkably,
the cell supernatants obtained from NKPSG cells had similar effect
(data not shown).
NKPSG cells secrete tolerogenic factors
Since the supernatant of NKPSG cells displayed immuno-
regulatory properties, we attempted to identify factors produced
Figure 4. Autonomous NK commitment of PB-HP: expression of Th2 transcription factors. (A) Western blotting detects a specific 110 kDa
band for pSTAT6 and a specific 48 kDa for GATA3 in the cell total lysate of PB-NKP but not of conventional NK cells. GATA3
+ Jurkat cells stimulated
with IL-4 were used as controls. (B Left panels) The expression of activated STAT6 and GATA3 was further confirmed, checking by confocal
microscopy the nuclear localization of phospho-STAT6 and GATA3 (yellow staining) in PB-NKP. These cells were fixed, permeabilized, and stained for
phopho-STAT6 or GATA3 transcription factors (green). Nuclei were stained by propidium iodide (red). As negative controls, cells were incubated with
rabbit IgG, the second reagent, and propidium iodide. (B Right panels) Effects of 24 hours pre-incubation of PB-NKP with the soluble IL-15Ra chain
(100 ng/ml for 60 min.) on the nuclear localization of phopho-STAT6 or GATA3. (C) Effects of 24 hours pre-incubation with the soluble IL-15Ra chain
on the intracellular production of the Th2 cytokines IL-5 and IL-4 in PB-NKP. Intracellular expression of cytokines (continuous black lines) is blocked
adding the soluble IL-15Ra chain (continuous red line) for 24 hours. Isotype controls (shadowed peaks).
doi:10.1371/journal.pone.0002241.g004
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effects. RT-PCR analysis (Fig. 8A) revealed that NKPSG cells
expressed the specific transcripts for IL-10 (403 bp). Production of
IL-10 was confirmed by the detection of discrete concentrations of
IL-10 (30–40 pg/ml) in the cell supernatants of NKPSG cells by
ELISA (Fig. 8A). As negative control, we used primary cultures of
human BM-derived mesenchymal stem cells [32] and IL-2
stimulated conventional NK cells, while human PB-derived
monocytes stimulated with LPS were used as positive controls.
In addition, Western blot analysis shows the presence of the
specific 36 kDa band (Fig. 8A), and flow cytometry analysis shows
that more than 80% of NKPSG cells express IL-10 as a membrane-
associated form, similarly to what previously reported in human
monocytes releasing IL-10 [23] (Fig. 8A).
Besides IL-10 [33], another cytokine displaying similar
tolerogenic effects on DC is IL-21 [34]. Thus, we investigated
the production of this latter cytokine by NKPSG. RT-PCR analysis
(Fig. 8B) revealed that NKPSG cells expressed the specific
transcripts for IL-21 (600 bp). Western blot analysis confirmed
the presence of IL-21 (Fig. 8B) in both total cell lysates (TL) and
cell supernatants (SN) from NKPSG cells and of HL-60 cells used
as positive control. Indeed, two specific bands of 15 and 18 kDa
representing the non-glycosylated and glycosylated forms were
detected in the TL of both cell types, whereas only the soluble
glycosylated form (18 kDa) was detected in their SN. Resting NK
cells showed no specific bands for IL-21.
IL-10 and IL-21 may account for the tolerogenic effects [33,34]
but they cannot explain the interference with the activation of NK-
mediated lysis [35,36]. Thus, we investigated whether NKPSG cells
could produce immuno-suppressive factors. Western blot analysis
(Fig. 8C) detected a specific band of 39 kDa which identifies the
membrane-bound form of HLA-G in TL from three-weeks-old
NKPSG cells and the M8-HLA-G1 tumor cell line used as positive
control [37]. IL-2-primed NK cells were used as negative control.
Moreover, Western blot analysis showed the presence of the
cleaved secreted isoform of HLA-G (36 kDa) in NKPSG and the
control M8-HLA-G1 cell supernatants. No 36 kDa band was
detected in the cell supernatants of IL-2-activated NK cells used as
negative controls. Finally, intracellular and membrane expression
of HLA-G by NKPSG was confirmed by flow cytometry (Fig 8C)
and by confocal microscopy (Fig. 8C).
IL-10, IL-21 and soluble HLA-G modulate the immuno-
regulatory properties of NKPSG cells
The secretion by NKPSG cells of potentially tolerogenic/
immunosuppressive factors led us to investigate the real involve-
ment of IL-10, IL-21 and soluble HLA-G in the immuno-
regulatory properties of these cells. Analysis of figure 9A shows
that less than 10% of PB-derived monocytes express on their
membrane HLA-G. Incubation of these cells with the cell
supernatants of NKPSG cells induces within 48 hours a strong
increase in the percentage of monocytes expressing HLA-G (70%).
In contrast, the addition of neutralizing anti-IL-10 mAbs
efficiently counteracts the stimulatory effect of the cell superna-
tants of NKPSG cells, decreasing to 35% the percentage of
monocytes positive for HLA-G membrane expression.
Figure 5. Interference on mb-IL-15 functions causes the down-regulation of NK markers. To test the hypothesis that PB-HP could be
committed into the NK pathway under the control of the endogenous mb-IL-15, IL-15 trans-presentation was blocked adding neutralizing IL-15Ra
(continuous red line) mAbs at the first and at the fourth day of the cell culture. Blocking IL-15Ra chain causes the inhibition of CD56, CD16 and CD161
expression (D4-D6), while the treatment preserves the initial level of CD34 expression (D4-D6). NK markers expression (continuous black lines).
Isotype controls (shadowed peaks).
doi:10.1371/journal.pone.0002241.g005
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efficiently counteract the inhibitory effects of NKPSG cells on the
membrane expression of CD107a and IFN-c induced on PB-
derived NK cells by the NCR cross-linking. In contrast,
neutralization of IL-10 with specific mAbs or of IL-21 with the
recombinant IL-21R/Fc chimera (s-IL-21R) had no effect (data
not shown).
Analysis of figure 9C shows that the treatment of myeloid mDC
with the supernatant of NKPSG cells strongly decreases within
48 hours the percentage of DC expressing HLA-DR, CD86 and
CD83, while it induces discrete levels of membrane-bound TGF-
b. In contrast, the combined neutralization of IL-21 (s-IL-21R)
and HLA-G (neutralizing mAbs) counteracts, much more
efficiently than the single treatments, the suppressive effects of
the cell supernatants re-establishing the expression of the above-
mentioned markers.
In vivo detection of NKp46
+ HLA-G
+ IL-10
+ NK cells
Finally, we investigated the existence in vivo of NK cell subsets
presenting characteristic similar to those of NKPSG cells that we
generate in vitro. Thus, we initially focused our study on the
pregnancy, a physiological situation where a subset of NK cells,
homing in the decidua (d-NK), spontaneously secrete IL-10 [38].
These d-NK display powerful regulatory properties, and low
Figure 6. NKPSG cells display regulatory functions on the maturation of myeloid dendritic cells and PB-derived monocytes. (A) Flow
cytometry show the modifications of the phenotype of mature myeloid dendritic cells (mDC, black lines), after co-culture of 3 weeks-old NKPSG cells
(continuous red lines) or conditioned supernatants of NKPSG cells (green lines). Control IgG1 (shadowed peaks). The data are representative of four
separate experiments. The data are representative of four separate experiments. (B) RAL 555 staining shows the morphology of LPS matured myeloid
DC before and after the co-culture with NKPSG cells (objective x40, NA=1). The data are representative of four separate experiments. mDC exhibit a
dendritic morphology underlined by the presence of typical vacuoles and fillopodial extensions whereas causes the rapid reshaping represented by
the appearance of healthy cells displaying the morphology of immature DC. (C) Nuclear localization of phospho-STAT3 (nuclear yellow staining) in
six-days-old mDC before and after 1 hour of contact with NKPSG cells was analyzed by confocal microscopy. DC were fixed, permeabilized, and
stained for phopho-STAT3 transcription factor (green). Nuclei were stained by propidium iodide (red). As negative controls, cells were incubated with
rabbit IgG, the second reagent, and propidium iodide. The data are representative of three separate experiments. (D) Flow cytometric analysis of the
proliferation potential in naı ¨ve allogeneic PBMC following CFSE staining. The black columns represent the percentage of proliferating cells. The data
are representative of three separate experiments. (E) Flow cytometric analysis of HLA-G molecules (continuous black line) on PB-derived monocytes
treated or not with supernatant of NKPSG cells. Isotype control (shadowed peak). The data are representative of three separate experiments.
doi:10.1371/journal.pone.0002241.g006
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foetomaternal tolerance [40]. The main functional hallmark of
NKPSG cells is the surface expression/release of the HLA-G
molecule, on the other hand, both membrane-bound and soluble
HLA-G isoforms are expressed in the placenta throughout
gestation playing major immunological functions and possibly
acting as regulators of chorionic villous angiogenesis [41].
Therefore, we tried to identify, within the d-NK cells, a subset
co-expressing NKp46, which at present is considered the most
reliable marker for NK cell identification, and HLA-G. In
figure 10, Dot plot analysis shows that freshly purified d-NK cells
constantly express a small subset of NKp46
+ HLA-G
+ cells which
represent about 3% of the total d-NK population. In addition, this
NKp46
+ HLA-G
+ subset produce IL-10. In contrast this subset is
not detected in the peripheral blood of pregnant women.
Discussion
Trans-presentation of membrane-bound IL-15 (mb-IL-15) by
BM-derived myeloid accessory cells to bystander lymphoid cells is
thought to represent an important mechanism to ensure the
homeostasis of CD8, NKT and NK cells [13,14,42-44]. It is likely
that similar interactions may also play a major role in the
development of NK cells. However, it was unclear whether IL-15
production by bystander CD34
+ HP was required for their
differentiation into NK cells [14,16]. In this study, we provide
experimental evidence that human PB-HP, but not BM-HP,
constitutively co-express two types of mb-IL-15. The first one
represents about 20% of the mb-IL-15 and is anchored to the cell
surface through the IL-15Ra chain. The second one, which is
predominant, likely represents a trans-membrane form as shown by
Figure 7. NKPSG cells interfere on the lytic functions of NK cells. Dot plot analysis shows CD107a and IFNc surface expression in conventional
IL-2 activated NK cells triggered (+ anti-NCR) or not (untreated) by NCR cross-linking and after 24 hours pre-incubation with NKPSG cells. In order to
distinguish co-cultured NK cells from NKPSG cells, these latter were stained with CFSE and excluded from cytometric analysis. The data are
representative of three separate experiments.
doi:10.1371/journal.pone.0002241.g007
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and by its resistance to treatment with acidic buffer [10]. The mb-
IL-15 present on these cells could mimic the effect exerted in vivo
by mb-IL-15 expressed on BM myeloid accessory cells [13,14] and
promote in vitro (by reciprocal trans-presentation) the commitment
of purified circulating progenitors towards the NK cell-lineage, in
the absence of exogenous lymphokines.
Our data strongly support this hypothesis since freshly isolated
CD34
+ CD38
+ PB-HP expanded in high density culture
conditions with STEMa A medium supplemented with SCF and
FL, rapidly acquire different NK cell markers (CD56, CD16,
CD161, CD94) while the expression of CD34 progressively
declines. Treatment with anti-IL-15Ra mAb likely interferes with
the mb-IL-15 trans-presentation process resulting in inhibition of
the NK markers and preservation of CD34 surface expression,
showing that, in the absence of any detectable IL-15 secretion, the
endogenous mb-IL-15 controls this process. After 3 weeks in
culture, cells displayed the surface phenotype of mature activated
NK cells (CD56
+ CD16
+ CD161
+ CD94
+ CD69
+ NKG2D
+
NKp30
+ NKp44
+ NKp46
+ CCR7
+). The activated state is
revealed by the acquisition of the NCR NKp44 and of the early
activation molecule CD69. The acquisition of the NKp46
receptor, the most reliable marker for NK cell identification
[45,46], indicates that these cells are truly differentiated NK cells
with the potential to migrate to secondary lymphoid compart-
ments as suggested by the expression of CCR7 [3].
Notably, they displayed a peculiar characteristic represented by
the nuclear localization of the Th2 transcription factors pSTAT6
Figure 8. NKPSG cells secrete immuno-regulatory factors. (A) Detection of IL-10 production by three-weeks-old NKPSG cells using : RT-PCR
analysis. The human neuroblastoma cell line Neuro2a was used as negative control, while human PBL activated with PHA and PMA were used as
positive control. Amplification of the same cDNAs with b-actin-specific primers is also shown. ELISA assay. Conventional PB-NK cells and BM-MSC
were used as negative controls while LPS- activated PB-macrophages were used as positive control. Western blot. recombinant IL-10 was used as
positive control. Flow cytometry. Detection of membrane bound IL-10 is represented with continuous black line. Isotype control (shadowed peak).
(B) Detection of IL-21 expression on three-weeks-old NKPSG cells using: RT-PCR analysis. The human neuroblastoma cell line Neuro2a was used as
negative control, while human PBL activated with PHA and PMA were used as positive control. Amplification of the same cDNAs with b-actin-specific
primers is also shown. Western blot. IL-21 expression was analyzed in total cell lysates (TL) and cell supernantants (SN) from NKPSG cells using mAbs
specific for IL-21. HL-60 cell line and recombinant IL-21 were used as positive controls. Conventional PB-NK cells were used as negative control. The
data are representative of three separate experiments. (C) Detection of HLA-G expression on three-weeks-old NKPSG cells using: Western blot. HLA-
G expression was analyzed in total cell lysates (TL) and cell supernantants (SN) from NKPSG cells using mAbs specific for HLA-G. M8-HLA-G1 cell line
was used as positive control. Conventional PB-NK cells were used as negative control. The data are representative of three separate experiments.
Flow cytometry. Detection of surface and intracellular expression of HLA-G on NKPSG cells is represented with continuous black line. Isotype control
(shadowed peaks). The data are representative of three separate experiments. Confocal microscopy. As negative controls, NKPSG cells were
incubated with Isotype-matched IgG1-FITC.
doi:10.1371/journal.pone.0002241.g008
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cytokines IL-4 and IL-5. The activation of the Th2 transcription
factors and the production of IL-4 and IL-5 seem to be directly
controlled by the mb-IL-15, as shown by their inhibition obtained
incubating PB-NKP with the soluble IL-15Ra chain. The soluble
ligand likely acts through an agonistic stimulation of mb-IL-15
activating a reverse signaling mechanism, even though we cannot
exclude that the soluble IL-15Ra may simply behave as an
antagonist interfering on the mb-IL-15 mediated trans-presentation
process.
Interestingly, these NKPSG cells did not display cytolytic
functions neither against K562 cells nor after mAb-mediated
triggering of CD16 and NCR receptors. We further investigated
their potential to interact with DC. Various evidences of the
reciprocal interactions between NK and DC have been accumu-
lated in recent years. The potent cross-talk between these cells may
lead to NK cell activation, DC activation or apoptosis, depending
on the activation status of the cells, with important functional
consequences on both innate and adaptive immune responses
[30]. Our results highlight new outcomes of NK-DC cross-talk
suggesting that NKPSG cells could act as a specialized subset able
to negatively shape DC maturation inducing the generation of
immature/tolerogenic myeloid DC. Indeed, NKPSG cells and/or
their conditioned supernatants rapidly induced in mDC the down-
regulation of HLA-DR, CD25, CD83, the co-stimulatory
molecules CD80 and CD86. In addition, they lost the ability to
produce IL-12 and to induce naive T cell proliferation. Finally, we
observed the induction of important functional markers associated
to the tolerogenic function such as the nuclear localization of
pSTAT3 [33] and the expression of membrane-bound TGF-b
[21,47] as well as a reversion to an immature DC morphology.
These data strongly support the concept that NKPSG cells may
display powerful regulatory properties causing the conversion of
mDC into immature/tolerogenic APC. Indeed, whether DC are
stimulatory or tolerogenic apparently rests with whether or not the
DC express activated STAT3 [33]. On the other hand, expression
of membrane-bound TGF-b on DC or Treg is responsible for the
inhibition of effector functions of T and NK cells [48,49]. In this
context, it is interesting to underline that the supernatant of
NKPSG cells induces the membrane expression of HLA-G on
human PB-derived monocytes that among circulatory mononu-
clear cells appear to be the predominant physiological source of
Figure 9. IL-10, IL-21 and HLA-G secreted by NKPSG cells act as immuno-regulatory factors. (A) Effect of incubation with neutralizing anti-
IL-10 mAbs (10 mg/ml) on the percentage of HLA-G positive human PB monocytes treated or not (untreated) with the cell supernantants from NKPSG
cells. (B) Effects of the incubation with neutralizing anti-HLA-G mAbs (10 mg/ml) on the percentage of CD107a and IFN-c on PB-derived NK positive
cells triggered with NCR cross-linking in the presence or not of NKPSG cells. (C) Effects of the incubation with neutralizing anti-HLA-G mAb and/or
soluble IL-21R (10 mg/ml) on the expression intensity (Mean Fluorescence Intensity) of HLA-DR, CD83, CD86 and mb-TGF-b on LPS-activated DC
cultured or not with cell supernantants from NKPSG cells.
doi:10.1371/journal.pone.0002241.g009
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of HLA-G expression on monocytes by NKPSG cell supernatants
strengthens the potential role of this NK subset in down-regulation
of the immune response. On the other hand, NKPSG cells
exhibited other important regulatory functions as they could
inhibit the acquisition of cytotoxicity-associated functions
(CD107a surface expression and IFN-c production) in NK cells
activated by cross-linking of NCR molecules. Since the superna-
tant of NKPSG cells at different times of their maturation process
(2 and 3 weeks-old cultures) could, at least in part, exert the same
regulatory effects, we searched for the secretion of tolerogenic
factors. In agreements with the expression of Th2 transcription
factors, pSTAT6 and GATA3, we showed that NKPSG cells
produced IL-10 and IL-21. The ability of NK cells to secrete
constitutively IL-10 has been recently reported in freshly isolated
NK cells from HCV patients but not from healthy donors [51].
Remarkably, the concentrations of IL-10 detected in the
supernatants of NKPSG cells are in the range of those secreted
by activated NK cells from HCV patients [51]. Therefore IL-10
secretion by NK-ireg cells is biologically relevant, as shown by the
fact that its inhibition with specific neutralizing mAbs efficiently
decreases the induction of HLA-G on monocytes. On the other
hand, the detection on NKPSG cells of IL-10 in a membrane-
associated form strongly recalls an identical property in human
monocytes and could be a new hallmark of the capacity described
in human activated NK cells to act as APC [4]. In contrast, it was
not known that human NK cells can secrete IL-21. Indeed, IL-21
production is considered to be restricted to different subsets of
human CD4 Th cells [52] and to BCG-activated murine NKT
cells [53]. Both IL-10 [33] and IL-21 [34] are known to alter DC
Figure 10. In vivo detection in freshly isolated decidual NK cells of a NKp46
+ HLA-G
+ IL-10
+ subset. (A) Dot plot analysis of expression of
NKp46 and HLA-G (surface labeling) in human freshly isolated decidual (d-NK) and PB-derived NK cells from pregnant woman (p-NK). Data are
representative of six independent experiments. (B) Expression of IL-10 (internal labeling) was analyzed on the gated positive NKp46
+ HLA-G
+ NK cell
subset.
doi:10.1371/journal.pone.0002241.g010
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between NK and DC and inhibit functional maturation of DC in
efficient APC. Furthermore, IL-21 production could explain the
rapid emergence of CD16
+ NKP, that was reported to occur only
when IL-21 was added to IL-15 during in vitro NK cell maturation
[54].
IL-10 and IL-21 are likely involved in the tolerogenic property of
NKPSG cells, but cannot be responsible for the NKPSG dependent
inhibition of NK cell activation triggered by NCR cross-linking
[35,54]. However, our data show that NKPSG cells express at their
surface and secrete HLA-G molecules that have been shown to
display immuno-regulatory properties interfering with DC matura-
tion and NK activation [37]. The surface expression and the
secretion of HLA-G are restricted to a very limited number of
normal tissues in which HLA-G molecules display important
immuno-regulatory functions [55]. The unusual expression and
secretion of HLA-G by NKPSG cells is demonstrated with four
different approaches: WB, flowcytometry, confocal microscopy and
biological assay using four different specific antibodies. The
biological importance of HLA-G in the regulatory functions of
NKPSG cells is shown through its neutralization with specific mAbs.
Indeed, this treatment efficiently counteracts the inhibitory effect
exerted by NKPSG cells on the surface expression of CD107a and
IFNc induced by NCR cross-linking on conventional PB-derived
NK cells. On the other hand, the combined neutralization of HLA-
G with a neutralizing mAb and of IL-21 with the soluble receptor s-
IL-21R efficiently counteracts the potential of NKPSG cells to
induce immature myeloid DC, underlying the complementary
tolerogenic properties of both factors.
In view of these properties, we propose the terminology ‘‘NK-
ireg’’ to define this NKPSG cells even if they do not express the
transcription factor Foxp3 and they cannot inhibit CD3
dependent T cell expansion (data not shown). We propose that
NK-ireg cells exert their immuno-regulatory potential acting
through the relay of accessory cells such as monocytes and mature
myeloid DC that acquire tolerogenic/suppressive properties after
contact with NK-ireg cells.
We cannot exclude that NK-ireg cells could be simply immature
NK cells that have not reached a stage in which they can secrete
lytic granules and IFN-c. Nevertheless, the fact that they cannot
differentiate into conventional cytolytic NK cells following
stimulation with IL-12, IL-15 and/or IL-18, associated to the
secretion of immuno-regulatory factors (IL-21 and HLA-G) not yet
detected in NK cells, and the expression of functional activation
markers such as NCR NKp44 and CD69, would rather suggest
that NK-ireg represent a novel truly differentiated NK subset with
a self-sustainable phenotype generated from specific pSTAT6
+
GATA3
+ progenitors and a distinguishing surface expression of
HLA-G molecules.
Recently, it has been reported the existence in the peripheral
blood of a small subset of immature CD3
2CD161
+CD56
2 NK
cells secreting Th2 cytokines (NK2) [56]. However, comparison of
this NK subset with NK-ireg cells reveals important differences
that render unlikely any hypothesis of a kinship. Indeed in NK2
cells, the absence of CD56 expression seems to represent a
characteristic associated to the final steps of their maturation,
while NK-ireg cells acquire CD56 expression very early in their
differentiation process. In addition, NK2 cells are very sensitive to
the cytokine environment which rapidly activates their develop-
mental progression towards the terminal differentiation. In
contrast, NK-ireg cells and their progenitors are resistant to
exogenous lymphokines and do not modify their phenotype and
function. The existence of human NK cells displaying regulatory
properties has been already hypothesized but not formally proven
[5]. In the present report, we describe the generation in vitro of
non-cytolytic regulatory NK cells whose differentiation is triggered
by a membrane-bound IL-15 constitutively expressed by PB-
derived HP but not by BM-derived ones.
The physiological significance of the NK-ireg would be
strengthened by the detection in vivo of NK cells displaying similar
phenotypic and functional characteristics. Therefore, we focused
our investigation to situations where has been reported the
presence of NK cells that display regulatory functions and
spontaneously secrete IL-10. In mouse and human, precursors of
NK cell lineage home to decidualizing uteri where they undergo
proliferation, terminal differentiation and then death. Decidual
NK (d-NK) cells are a distinct, transient, tissue-specific NK cell
subset that during pregnancy increase along the first trimester,
then decline and are virtually absent in late pregnancy. The d-NK
cells spontaneously secrete IL-10 and are thought to contribute to
placental angiogenesis and to play a significant role in the
allorecognition mechanisms during pregnancy regulating the
maternal tolerance at the foetomaternal interface. Our data show
that freshly isolated d-NK cells express a small subset (3–4%) of
NKp46
+ HLA-G
+ CD56
bright cells that could represent an in vivo
counterpart of the NK-ireg that we have generated in vitro.
Use of immunosupressive drugs for the prevention of allograft
rejection is associated with heavy side effects and toxicity [57]. In
this context, the use of immuno-regulatory cells such as
mesenchymal stem cells (MSC) is viewed as an interesting and
promising alternative with decreased side effects [58]. Since the
NK-ireg cells, that we generate in vitro from PB-HP, display
immuno-regulatory properties similar to those reported in MSC
[59,60], we propose that this novel NK subset could constitute an
additional autologous biotherapic tool to be used combined or in
alternative to MSC. On the other hand, it must be stated that
obtention and expansion of MSC requires bone marrow biopsies,
while NK-ireg cells are derived from peripheral blood of the
patient receiving an allograft.
In conclusion, the in vitro generation and expansion of NK-ireg
cells could offer interesting perspectives for the development of
new immuno-suppressive strategies in autoimmune diseases,
transplant rejection or graft versus host disease.
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